Skip to main content
. 2021 Jul 6;21:1330. doi: 10.1186/s12889-021-11431-2

Table 4.

Odds Ratios for In-Hospital Mortality among Non-Hispanic Black (vs. Non-Hispanic White) and Hispanic (vs. Non-Hispanic) Hospitalized COVID-19 Patients

Model 1

OR (95% CI)a

(n = 1887)

Model 2

OR (95% CI)a

(n = 1835)

Model 3

OR (95% CI)a

(n = 1835)

Model AICb 908.51 796.86 682.03
Non-Hispanic Black (vs. NHW) 0.96 (0.65, 1.40) 0.72 (0.47, 1.09) 0.65 (0.40, 1.03)
Demographic Factors
 Age, in 5-year units 1.25 (1.16, 1.35) 1.26 (1.16, 1.38) 1.31 (1.20, 1.45)
 Female (vs. Male) 0.82 (0.56, 1.18) 1.13 (0.76, 1.69) 1.00 (0.64, 1.56)
 Residence: Low Income ZIP Codec 1.00 (0.69, 1.44) 0.95 (0.64, 1.40) 0.95 (0.62, 1.47)
 Charlson Comorbidity Index Score 1.11 (1.05, 1.17) 1.09 (1.03, 1.16) 1.03 (0.96, 1.10)
 Obesity 1.14 (0.76, 1.70) 1.18 (0.77, 1.81) 1.04 (0.65, 1.67)
 Hypertension 1.24 (0.68, 2.44) 0.91 (0.48, 1.85) 0.81 (0.39, 1.77)
 Smoking (Current/Former) 1.14 (0.77, 1.67) 1.04 (0.69, 1.57) 1.11 (0.71, 1.74)
Vital Signs
 Respiratory Rate ≥ 24 breath / min 1.80 (1.16, 2.75) 1.29 (0.79, 2.08)
 Oxygen Saturation < 94% 1.94 (1.21, 3.09) 1.75 (1.03, 2.93)
Laboratory Parameters
 Lymphocytes < 20% 3.05 (1.77, 5.57) 2.30 (1.27, 4.41)
 Platelet count < 150,000/μl 2.02 (1.26, 3.20) 1.93 (1.14, 3.25)
 Aspartate aminotransferase > 40 U/l 2.32 (1.46, 3.72) 2.18 (1.31, 3.66)
 Alanine aminotransferase > 40 U/l 1.04 (0.66, 1.66) 0.76 (0.45, 1.28)
 Creatinine > 1.5 mg/dl 2.99 (1.97, 4.55) 2.20 (1.37, 3.55)
Hospital Complications
 Pneumonia 1.04 (0.58, 1.90)
 ARDS 5.53 (2.60, 11.91)
 Hypoxic Respiratory Failure 3.68 (2.15, 6.45)
 Acute Renal Injury 1.88 (1.17, 3.01)
 Acute Hepatic Injury 1.23 (0.40, 3.61)
 Cardiomyopathy or CHF 1.10 (0.67, 1.77)
Therapeutics 0.56 (0.26, 1.12)
 Remdesivir 0.56 (0.26, 1.12)
 Dexamethasone 0.64 (0.40, 1.00)
ICU Admission 3.43 (2.08, 5.72)

Model 1

OR (95% CI)a

(n = 3454)

Model 2

OR (95% CI)a

(n = 3369)

Model 3

OR (95% CI)a

(n = 3369)

Model AICb 1468.1 1261.7 1012.8
Hispanic (vs. Non-Hispanic) 1.12 (0.80, 1.54) 0.95 (0.67, 1.34) 0.89 (0.59, 1.31)
Demographic Factors
 Age, in 5-year units 1.27 (1.20, 1.35) 1.29 (1.21, 1.39) 1.35 (1.25, 1.46)
 Female (vs. Male) 0.78 (0.58, 1.04) 1.09 (0.80, 1.49) 0.93 (0.65, 1.32)
 Residence: Low Income ZIP Codec 0.95 (0.72, 1.28) 0.87 (0.64, 1.18) 0.88 (0.63, 1.25)
 Charlson Comorbidity Index Score 1.11 (1.06, 1.16) 1.09 (1.04, 1.14) 1.02 (0.96, 1.08)
 Obesity 1.30 (0.94, 1.78) 1.34 (0.95, 1.88) 1.08 (0.73, 1.58)
 Hypertension 1.38 (0.88, 2.21) 1.09 (0.68, 1.78) 0.88 (0.52, 1.54)
 Smoking (Current/Former) 1.16 (0.84, 1.60) 1.12 (0.79, 1.58) 1.25 (0.85, 1.84)
Vital Signs
 Respiratory Rate ≥ 24 breath / min 1.44 (1.02, 2.01) 1.13 (0.77, 1.66)
 Oxygen Saturation < 94% 2.33 (1.64, 3.31) 1.90 (1.27, 2.84)
Laboratory Parameters
 Lymphocytes < 20% 3.45 (2.14, 5.86) 2.31 (1.36, 4.08)
 Platelet count < 150,000/μl 1.99 (1.37, 2.86) 1.60 (1.03, 2.45)
 Aspartate aminotransferase > 40 U/l 2.88 (1.96, 4.27) 2.47 (1.61, 3.82)
 Alanine aminotransferase > 40 U/l 1.14 (0.80, 1.64) 0.74 (0.49, 1.13)
 Creatinine > 1.5 mg/dl 3.04 (2.18, 4.23) 1.98 (1.35, 2.89)
Hospital Complications
 Pneumonia 1.00 (0.60, 1.67)
 ARDS 7.02 (3.82, 13.12)
 Hypoxic Respiratory Failure 3.67 (2.27, 6.07)
 Acute Renal Injury 2.04 (1.40, 2.97)
 Acute Hepatic Injury 3.31 (1.46, 7.58)
 Cardiomyopathy or CHF 1.21 (0.80, 1.80)
Therapeutics
 Remdesivir 0.57 (0.34, 0.95)
 Dexamethasone 0.73 (0.51, 1.06)
ICU Admission 4.55 (2.97, 7.08)

AIC Akaike information criterion, ARDS Acute Respiratory Distress Syndrome, CHF Congestive Heart Failure

a Adjusted Odds Ratios and 95% Confidence Intervals for association between individual co-variates and in-hospital mortality among confirmed COVID-19 cases

b Model Akaike information criterion (AIC)

c Low income classified as ZIP codes in the 2 lowest pentiles for median house income